CLOs on the Move

SeaSpine

www.seaspine.com

 
Our SeaSpine family is dedicated to collaborating with surgeons to develop cost effective solutions to treat spinal disorders. We do this by providing high quality, differentiated and complementary technologies that leverage our core competencies in orthobiologics, interbody devices and modular spinal instrumentation systems.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Patrick Keran
General Counsel Profile

Similar Companies

Emboline, Inc.

Emboline is a medical device company with a game-changing device for total embolic protection during percutaneous heart valve repair and replacement procedures and other cardiovascular procedures with embolic risks.

Omega Medical Imaging

Omega Medical Imaging is a Sanford, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Meddius

Meddius is a Charlottesville, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rynel

Rynel is a Wiscasset, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Contego Medical

Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical sequalae. Despite knowing that embolization is ubiquitous, embolic protection devices are not used in all procedures as they add complexity, time, and cost. Dedicated devices do not exist for renal intervention, although the majority of physicians say they would use one if it existed. Contego Medical’s family of embolic protection devices represent a paradigm shift in the treatment of cardiovascular disease.